tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jenscare Scientific Reports Reduced Losses and Advances in Valve Replacement Technology

Story Highlights
Jenscare Scientific Reports Reduced Losses and Advances in Valve Replacement Technology

TipRanks Black Friday Sale

Jenscare Scientific Co. Ltd. Class H ( (HK:9877) ) just unveiled an update.

Jenscare Scientific Co., Ltd. announced a significant reduction in its annual losses for 2024, with a 51% decrease in loss before income tax compared to the previous year. The company is actively commercializing its Ken-Valve product following recent regulatory approvals, while its LuX-Valve Plus has shown promising clinical results, reinforcing its competitive position in the global market.

More about Jenscare Scientific Co. Ltd. Class H

Jenscare Scientific Co., Ltd. is a joint stock company incorporated in China, focusing on the medical device industry. The company specializes in transcatheter valve replacement products, including the LuX-Valve series for tricuspid valve replacement and Ken-Valve for aortic valve replacement, aiming to expand its global market presence.

YTD Price Performance: 29.66%

Average Trading Volume: 207,010

Technical Sentiment Consensus Rating: Hold

Current Market Cap: HK$2.47B

For an in-depth examination of 9877 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1